Nottingham Forest striker Lyle Taylor will go pink during the month of October to raise awareness for the fantastic work done by Cancer Research UK.
Following on from two successful Pink Octobers during his time at Charlton Athletic, Lyle is launching the campaign once again and is hoping as many Reds fans can help to support him in his quest.
Lyle has dyed his hair pink and will wear pink boots for all six matches during the month while there be plenty of other awareness and fundraising events happening throughout October that Forest fans are encouraged to get involved with. Keep an eye on nottinghamforest.co.uk and the club's social media channels for more information.
He said: “In my family, three of my grandparents have suffered with bowel and prostate cancer. Thankfully, they have survived it and are healthy and enjoying their lives to the fullest extent. My aunt's mum and nan's best friend both had breast cancer and unfortunately passed away. Raising money towards cancer research is something that is important to me, simply because I've seen people so close to me suffer and, in the worst cases, lose that fight.
“I am using the colour pink, which is associated with Breast Cancer and the month of October, Cancer Awareness Month to raise awareness and money for Cancer Research UK. During the month of October, I will, as a professional footballer for Nottingham Forest, wear pink football boots and dye my hair pink, hoping that this will create a visual aid and raise awareness for the phenomenal work done by Cancer Research UK.”
To donate to Lyle’s Pink October campaign, please visit https://fundraise.cancerresearchuk.org/unite/lyles-pink-october.
A bit more from Cancer Research UK
Cancer Research UK’s vision is to bring forward the day when all cancers are cured.
Thanks to our supporters, our pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. In the 1970s, less than a quarter of people with cancer survived. But over the last 40 years, survival rates have doubled and today half of those people will survive. Our ambition is to accelerate progress and see three-quarters of people surviving the disease by 2034.
However, COVID-19 threatens to severely impact our cancer research and making our ambition of improving cancer survival to 3 in 4 by 2034 more difficult. Unfortunately, COVID-19 has hit our fundraising hard and we’re predicting a drop in income of £160million this year. As the pandemic continues, our need for support has never been greater. Vital research has been paused and we have already been forced to make £44million of cuts to research spend this year, and we’ll need to reduce the amount of research we fund annually.